GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » FCF Yield %

BBS-Bioactive Bone Substitutes (OHEL:BONEH) FCF Yield % : -39.71 (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BBS-Bioactive Bone Substitutes's Trailing 12-Month Free Cash Flow is €-2.92 Mil, and Market Cap is €7.36 Mil. Therefore, BBS-Bioactive Bone Substitutes's FCF Yield % for today is -39.71%.

The historical rank and industry rank for BBS-Bioactive Bone Substitutes's FCF Yield % or its related term are showing as below:

OHEL:BONEH' s FCF Yield % Range Over the Past 10 Years
Min: -49.13   Med: 0   Max: 0
Current: -39.71


OHEL:BONEH's FCF Yield % is ranked worse than
84.94% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.815 vs OHEL:BONEH: -39.71

BBS-Bioactive Bone Substitutes's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


BBS-Bioactive Bone Substitutes FCF Yield % Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes FCF Yield % Chart

BBS-Bioactive Bone Substitutes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -14.10 -7.99 -17.92 -25.05 -30.98

BBS-Bioactive Bone Substitutes Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.90 -28.60 -23.35 -45.62 -31.62

Competitive Comparison of BBS-Bioactive Bone Substitutes's FCF Yield %

For the Medical Devices subindustry, BBS-Bioactive Bone Substitutes's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BBS-Bioactive Bone Substitutes's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BBS-Bioactive Bone Substitutes's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BBS-Bioactive Bone Substitutes's FCF Yield % falls into.



BBS-Bioactive Bone Substitutes FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BBS-Bioactive Bone Substitutes's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.923 / 9.4363308
=-30.98%

BBS-Bioactive Bone Substitutes's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.492 * 2 / 9.4363308
=-31.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BBS-Bioactive Bone Substitutes FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BBS-Bioactive Bone Substitutes FCF Yield % Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Traded in Other Exchanges
N/A
Address
Kiviharjunlenkki 6, Oulu, FIN, 90220
BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines